Global Benign Prostatic Hyperplasia (BPH) Treatment Market - Industry Analysis Size Share Growth Trends and Forecast 2022 - 2030

Global Benign Prostatic Hyperplasia (BPH) Treatment Market - Industry Analysis Size Share Growth Trends and Forecast 2022 - 2030

  • SKU :
    SAC2045049
  • Published Date :
    June 1, 2022
  • Number of Pages :
    300.0

Product Description

Benign prostatic hyperplasia (BPH), also called prostate enlargement, is a noncancerous increase in size of the prostate gland. Symptoms may include frequent urination, trouble starting to urinate, weak stream, inability to urinate, or loss of bladder control. Medication is the most common treatment for mild to moderate symptoms of prostate enlargement.  The options include:Alpha Blocker, 5- Alpha, Reductase Inhibitor, Phosphodiesterase-5 Inhibitor.
The Benign Prostatic Hyperplasia (BPH) Treatment market revenue was xx Million USD in 2018, grew to xx Million USD in 2021, and will reach xx Million USD in 2030, with a CAGR of xx during 2022-2030.

Considering the influence of COVID-19 on the global Benign Prostatic Hyperplasia (BPH) Treatment market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.

This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.

Under COVID-19 Outbreak, how the Benign Prostatic Hyperplasia (BPH) Treatment Industry will develop is also analyzed in detail in Chapter 1.8 of this report.

Major Players in Benign Prostatic Hyperplasia (BPH) Treatment market are:
Eli Lilly and Company
Astellas Pharma, Inc.
Abbott Laboratories
Teva Pharmaceutical Industries Limited
Sanofi
GlaxoSmithKline plc
Pfizer, Inc.
Boehringer Ingelheim Pharma GmbH & Co. KG
Merck & Co., Inc.
Allergan plc

Most important types of Benign Prostatic Hyperplasia (BPH) Treatment products covered in this report are:
Pharmaceutical
Surgical

Most widely used downstream fields of Benign Prostatic Hyperplasia (BPH) Treatment market covered in this report are:
Hospital
Clinic

Major Regions or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others

In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.

In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.

In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.

Table of Content 

Table of Content

1 Benign Prostatic Hyperplasia (BPH) Treatment Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Benign Prostatic Hyperplasia (BPH) Treatment
1.3 Benign Prostatic Hyperplasia (BPH) Treatment Market Scope and Market Size Estimation
1.3.1 Market Concentration Ratio and Market Maturity Analysis
1.3.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate from 2018-2030
1.4 Market Segmentation
1.4.1 Types of Benign Prostatic Hyperplasia (BPH) Treatment
1.4.2 Applications of Benign Prostatic Hyperplasia (BPH) Treatment
1.4.3 Research Regions
1.5 Market Dynamics
1.5.1 Benign Prostatic Hyperplasia (BPH) Treatment Industry Trends
1.5.2 Benign Prostatic Hyperplasia (BPH) Treatment Drivers
1.5.3 Benign Prostatic Hyperplasia (BPH) Treatment Market Challenges
1.5.4 Benign Prostatic Hyperplasia (BPH) Treatment Market Restraints
1.6 Industry News and Policies by Regions
1.6.1 Industry News
1.6.2 Industry Policies
1.7 Mergers & Acquisitions, Expansion Plans
1.8 Benign Prostatic Hyperplasia (BPH) Treatment Industry Development Trends under COVID-19 Outbreak
1.8.1 Global COVID-19 Status Overview
1.8.2 Influence of COVID-19 Outbreak on Benign Prostatic Hyperplasia (BPH) Treatment Industry Development

2 Industry Chain Analysis
2.1 Upstream Raw Material Supply and Demand Analysis
2.1.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Major Upstream Raw Material and Suppliers
2.1.2 Raw Material Source Analysis
2.2 Major Players of Benign Prostatic Hyperplasia (BPH) Treatment
2.2.1 Major Players Manufacturing Base of Benign Prostatic Hyperplasia (BPH) Treatment in 2020
2.2.2 Major Players Market Distribution in 2020
2.3 Benign Prostatic Hyperplasia (BPH) Treatment Manufacturing Cost Structure Analysis
2.3.1 Production Process Analysis
2.3.2 Manufacturing Cost Structure of Benign Prostatic Hyperplasia (BPH) Treatment
2.3.3 Labor Cost of Benign Prostatic Hyperplasia (BPH) Treatment
2.4 Market Channel Analysis of Benign Prostatic Hyperplasia (BPH) Treatment
2.5 Major Down Stream Customers by Application

3 Global Benign Prostatic Hyperplasia (BPH) Treatment Market, by Type
3.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Market Share by Type (2018-2021)
3.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Production and Market Share by Type (2018-2021)
3.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate by Type (2018-2021)
3.3.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate of Pharmaceutical
3.3.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate of Surgical
3.4 Global Benign Prostatic Hyperplasia (BPH) Treatment Price Analysis by Type (2018-2021)
3.4.1 Explanation of Different Type Product Price Trends

4 Benign Prostatic Hyperplasia (BPH) Treatment Market, by Application
4.1 Downstream Market Overview
4.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Consumption and Market Share by Application (2018-2021)
4.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Consumption and Growth Rate by Application (2018-2021)
4.3.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Consumption and Growth Rate of Hospital (2018-2021)
4.3.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Consumption and Growth Rate of Clinic (2018-2021)

5 Global Benign Prostatic Hyperplasia (BPH) Treatment Consumption, Revenue ($) by Region (2018-2021)
5.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Market Share by Region (2018-2021)
5.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Consumption and Market Share by Region (2018-2021)
5.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Consumption, Revenue, Price and Gross Margin (2018-2021)
5.4 North America Benign Prostatic Hyperplasia (BPH) Treatment Consumption, Revenue, Price and Gross Margin (2018-2021)
5.4.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Market Under COVID-19
5.4.2 North America Benign Prostatic Hyperplasia (BPH) Treatment SWOT Analysis
5.5 Europe Benign Prostatic Hyperplasia (BPH) Treatment Consumption, Revenue, Price and Gross Margin (2018-2021)
5.5.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Under COVID-19
5.5.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment SWOT Analysis
5.6 China Benign Prostatic Hyperplasia (BPH) Treatment Consumption, Revenue, Price and Gross Margin (2018-2021)
5.6.1 China Benign Prostatic Hyperplasia (BPH) Treatment Market Under COVID-19
5.6.2 China Benign Prostatic Hyperplasia (BPH) Treatment SWOT Analysis
5.7 Japan Benign Prostatic Hyperplasia (BPH) Treatment Consumption, Revenue, Price and Gross Margin (2018-2021)
5.7.1 Japan Benign Prostatic Hyperplasia (BPH) Treatment Market Under COVID-19
5.7.2 Japan Benign Prostatic Hyperplasia (BPH) Treatment SWOT Analysis
5.8 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Consumption, Revenue, Price and Gross Margin (2018-2021)
5.8.1 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Under COVID-19
5.8.2 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment SWOT Analysis
5.9 India Benign Prostatic Hyperplasia (BPH) Treatment Consumption, Revenue, Price and Gross Margin (2018-2021)
5.9.1 India Benign Prostatic Hyperplasia (BPH) Treatment Market Under COVID-19
5.9.2 India Benign Prostatic Hyperplasia (BPH) Treatment SWOT Analysis
5.10 South America Benign Prostatic Hyperplasia (BPH) Treatment Consumption, Revenue, Price and Gross Margin (2018-2021)
5.10.1 South America Benign Prostatic Hyperplasia (BPH) Treatment Market Under COVID-19
5.10.2 South America Benign Prostatic Hyperplasia (BPH) Treatment SWOT Analysis
5.11 South Korea Benign Prostatic Hyperplasia (BPH) Treatment Consumption, Revenue, Price and Gross Margin (2018-2021)
5.11.1 South Korea Benign Prostatic Hyperplasia (BPH) Treatment Market Under COVID-19
5.11.2 South Korea Benign Prostatic Hyperplasia (BPH) Treatment SWOT Analysis
5.12 Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Consumption, Revenue, Price and Gross Margin (2018-2021)
5.12.1 Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Market Under COVID-19
5.12.2 Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment SWOT Analysis

6 Global Benign Prostatic Hyperplasia (BPH) Treatment Production by Top Regions (2018-2021)
6.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Production by Top Regions (2018-2021)
6.2 North America Benign Prostatic Hyperplasia (BPH) Treatment Production and Growth Rate
6.3 Europe Benign Prostatic Hyperplasia (BPH) Treatment Production and Growth Rate
6.4 China Benign Prostatic Hyperplasia (BPH) Treatment Production and Growth Rate
6.5 Japan Benign Prostatic Hyperplasia (BPH) Treatment Production and Growth Rate
6.6 India Benign Prostatic Hyperplasia (BPH) Treatment Production and Growth Rate

7 Global Benign Prostatic Hyperplasia (BPH) Treatment Consumption by Regions (2018-2021)
7.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Consumption by Regions (2018-2021)
7.2 North America Benign Prostatic Hyperplasia (BPH) Treatment Consumption and Growth Rate
7.3 Europe Benign Prostatic Hyperplasia (BPH) Treatment Consumption and Growth Rate
7.4 China Benign Prostatic Hyperplasia (BPH) Treatment Consumption and Growth Rate
7.5 Japan Benign Prostatic Hyperplasia (BPH) Treatment Consumption and Growth Rate
7.6 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Consumption and Growth Rate
7.7 India Benign Prostatic Hyperplasia (BPH) Treatment Consumption and Growth Rate
7.8 South America Benign Prostatic Hyperplasia (BPH) Treatment Consumption and Growth Rate
7.9 South Korea Benign Prostatic Hyperplasia (BPH) Treatment Consumption and Growth Rate
7.10 Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Consumption and Growth Rate

8 Competitive Landscape
8.1 Competitive Profile
8.2 Eli Lilly and Company Market Performance Analysis
8.2.1 Company Profiles
8.2.2 Benign Prostatic Hyperplasia (BPH) Treatment Product Profiles, Application and Specification
8.2.3 Eli Lilly and Company Sales, Revenue, Price, Gross Margin 2018-2021
8.2.4 Company Recent Development
8.2.5 Strategies for Company to Deal with the Impact of COVID-19
8.3 Astellas Pharma, Inc. Market Performance Analysis
8.3.1 Company Profiles
8.3.2 Benign Prostatic Hyperplasia (BPH) Treatment Product Profiles, Application and Specification
8.3.3 Astellas Pharma, Inc. Sales, Revenue, Price, Gross Margin 2018-2021
8.3.4 Company Recent Development
8.3.5 Strategies for Company to Deal with the Impact of COVID-19
8.4 Abbott Laboratories Market Performance Analysis
8.4.1 Company Profiles
8.4.2 Benign Prostatic Hyperplasia (BPH) Treatment Product Profiles, Application and Specification
8.4.3 Abbott Laboratories Sales, Revenue, Price, Gross Margin 2018-2021
8.4.4 Company Recent Development
8.4.5 Strategies for Company to Deal with the Impact of COVID-19
8.5 Teva Pharmaceutical Industries Limited Market Performance Analysis
8.5.1 Company Profiles
8.5.2 Benign Prostatic Hyperplasia (BPH) Treatment Product Profiles, Application and Specification
8.5.3 Teva Pharmaceutical Industries Limited Sales, Revenue, Price, Gross Margin 2018-2021
8.5.4 Company Recent Development
8.5.5 Strategies for Company to Deal with the Impact of COVID-19
8.6 Sanofi Market Performance Analysis
8.6.1 Company Profiles
8.6.2 Benign Prostatic Hyperplasia (BPH) Treatment Product Profiles, Application and Specification
8.6.3 Sanofi Sales, Revenue, Price, Gross Margin 2018-2021
8.6.4 Company Recent Development
8.6.5 Strategies for Company to Deal with the Impact of COVID-19
8.7 GlaxoSmithKline plc Market Performance Analysis
8.7.1 Company Profiles
8.7.2 Benign Prostatic Hyperplasia (BPH) Treatment Product Profiles, Application and Specification
8.7.3 GlaxoSmithKline plc Sales, Revenue, Price, Gross Margin 2018-2021
8.7.4 Company Recent Development
8.7.5 Strategies for Company to Deal with the Impact of COVID-19
8.8 Pfizer, Inc. Market Performance Analysis
8.8.1 Company Profiles
8.8.2 Benign Prostatic Hyperplasia (BPH) Treatment Product Profiles, Application and Specification
8.8.3 Pfizer, Inc. Sales, Revenue, Price, Gross Margin 2018-2021
8.8.4 Company Recent Development
8.8.5 Strategies for Company to Deal with the Impact of COVID-19
8.9 Boehringer Ingelheim Pharma GmbH & Co. KG Market Performance Analysis
8.9.1 Company Profiles
8.9.2 Benign Prostatic Hyperplasia (BPH) Treatment Product Profiles, Application and Specification
8.9.3 Boehringer Ingelheim Pharma GmbH & Co. KG Sales, Revenue, Price, Gross Margin 2018-2021
8.9.4 Company Recent Development
8.9.5 Strategies for Company to Deal with the Impact of COVID-19
8.10 Merck & Co., Inc. Market Performance Analysis
8.10.1 Company Profiles
8.10.2 Benign Prostatic Hyperplasia (BPH) Treatment Product Profiles, Application and Specification
8.10.3 Merck & Co., Inc. Sales, Revenue, Price, Gross Margin 2018-2021
8.10.4 Company Recent Development
8.10.5 Strategies for Company to Deal with the Impact of COVID-19
8.11 Allergan plc Market Performance Analysis
8.11.1 Company Profiles
8.11.2 Benign Prostatic Hyperplasia (BPH) Treatment Product Profiles, Application and Specification
8.11.3 Allergan plc Sales, Revenue, Price, Gross Margin 2018-2021
8.11.4 Company Recent Development
8.11.5 Strategies for Company to Deal with the Impact of COVID-19

9 Global Benign Prostatic Hyperplasia (BPH) Treatment Market Analysis and Forecast by Type and Application
9.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Market Revenue & Volume Forecast, by Type (2021-2026)
9.1.1 Pharmaceutical Market Revenue and Volume Forecast (2021-2026)
9.1.2 Surgical Market Revenue and Volume Forecast (2021-2026)
9.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Market Revenue & Volume Forecast, by Application (2021-2026)
9.2.1 Hospital Market Revenue and Volume Forecast (2021-2026)
9.2.2 Clinic Market Revenue and Volume Forecast (2021-2026)

10 Benign Prostatic Hyperplasia (BPH) Treatment Market Supply and Demand Forecast by Region
10.1 North America Market Supply and Demand Forecast (2021-2026)
10.2 Europe Market Supply and Demand Forecast (2021-2026)
10.3 China Market Supply and Demand Forecast (2021-2026)
10.4 Japan Market Supply and Demand Forecast (2021-2026)
10.5 Middle East and Africa Market Supply and Demand Forecast (2021-2026)
10.6 India Market Supply and Demand Forecast (2021-2026)
10.7 South America Market Supply and Demand Forecast (2021-2026)
10.8 South Korea Market Supply and Demand Forecast (2021-2026)
10.9 Southeast Asia Market Supply and Demand Forecast (2021-2026)
10.10 Explanation of Market Size Trends by Region
10.11 Benign Prostatic Hyperplasia (BPH) Treatment Market Trends Analysis

11 New Project Feasibility Analysis
11.1 Industry Barriers and New Entrants SWOT Analysis
11.2 Analysis and Suggestions on New Project Investment

12 Expert Interview Record
13 Research Finding and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Data Source
?

Search results for Healthcare IT Industry

Select License Type

get a sample
Ask For Customization
Get a quote
Speak to Analyst
Buy Now

Automobile and Transportation

Energy and Mining

Food and Beverages

Top Rated Products